Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Hepatitis C

Free Subscription Articles published in Hepatology Retrieve available abstracts of 235 articles: HTML format

Single Articles

June 2008
1. POCKROS PJ , Nelson D, Godofsky E, Rodriguez-Torres M, et al
   R1626 plus peginterferon Alfa-2a provides potent suppression of hepatitis C virus RNA and significant antiviral synergy in combination with ribavirin.
   Hepatology. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
2. PIODI A , Chouteau P, Lerat H, Hezode C, et al
   Morphological changes in intracellular lipid droplets induced by different hepatitis C virus genotype core sequences and relationship with steatosis.
   Hepatology. 2008;48:16-27.
   PubMed     Related articles    Abstract available
   
   
   
3. HARRIS RA , Sugimoto K, Kaplan DE, Ikeda F, et al
   Human leukocyte antigen class II associations with hepatitis C virus clearance and virus-specific CD4 T cell response among Caucasians and African Americans.
   Hepatology. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
4. PHAM TN , Michalak TI
   Hepatitis C virus in peripheral blood mononuclear cells of individuals with isolated anti-hepatitis C virus antibody reactivity.
   Hepatology. 2008;.
   PubMed     Related articles   
   
   
   
5. SCHIAVON LL , Carvalho-Filho RJ, Narciso-Schiavon JL, Barbosa DV, et al
   Impact of cyclosporine-based immunosuppressive therapy on liver histology of hepatitis C virus-infected renal transplant patients.
   Hepatology. 2008;.
   PubMed     Related articles   
   
   
   
6. SANZ-CAMENO P , Martin-Vilchez S, Rodriguez-Munoz Y, Moreno-Otero R, et al
   Implicaton of tetraspanin-enriched microdomains (TEMs) in hepatitis C virus.
   Hepatology. 2008;.
   PubMed     Related articles   
   
   
   May 2008
7. POLYAK SJ , Morishima C, Hawke R
   Antiviral effects of silymarin against hepatitis C: The jury is still out.
   Hepatology. 2008;.
   PubMed     Related articles   
   
   
   
8. MORCOS PN , Brennan B, Smith PF
   A grapefruit a day for patients infected with hepatitis C?
   Hepatology. 2008;47:2141-2142.
   PubMed     Related articles   
   
   
   
9. TORRES DM , Harrison SA
   Insulin resistance in chronic hepatitis C, genotypes 1 and 4: The unfortunate reality.
   Hepatology. 2008;47:2137-2139.
   PubMed     Related articles   
   
   
   
10. YU ML , Dai CY, Huang JF, Chiu CF, et al
    Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: A randomized trial.
    Hepatology. 2008;47:1884-1893.
    PubMed     Related articles    Abstract available
    
    
    
11. MORENO-OTERO R , Trapero M, Moreno-Monteagudo JA
    Chronic hepatitis C genotype 2 or 3 short treatment.
    Hepatology. 2008;47:1796.
    PubMed     Related articles   
    
    
    April 2008
12. THEIN HH , Yi Q, Dore GJ, Krahn MD, et al
    Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
13. SCHAFER DF
    Chronic genotype 4 hepatitis C.
    Hepatology. 2008;.
    PubMed     Related articles   
    
    
    
14. JACOBSON IM , Brown RS Jr
    WIN-R revisited: Response to editorial.
    Hepatology. 2008;47:1427.
    PubMed     Related articles   
    
    
    March 2008
15. ZEKRY A , Freiman J
    Eltrombopag: Is this "24 karat gold platelet" treatment for thrombocytopenia in cirrhosis associated with hepatitis C?
    Hepatology. 2008;47:1418-1421.
    PubMed     Related articles   
    
    
    
16. EBIHARA T , Shingai M, Matsumoto M, Wakita T, et al
    Hepatitis C virus-infected hepatocytes extrinsically modulate dendritic cell maturation to activate T cells and natural killer cells.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
17. EL-SHAMY A , Nagano-Fujii M, Sasase N, Imoto S, et al
    Sequence variation in hepatitis C virus nonstructural protein 5A predicts clinical outcome of pegylated interferon/ribavirin combination therapy.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
18. ROBERTS SK , Cooksley G, Dore GJ, Robson R, et al
    Robust antiviral activity of R1626, a novel nucleoside analog: A randomized, placebo-controlled study in patients with chronic hepatitis C.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
19. PETTA S , Camma C, Di Marco V, Alessi N, et al
    Retinol-binding protein 4: A new marker of virus-induced steatosis in patients infected with hepatitis c virus genotype 1.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
20. SWAN T , Chung RT
    Development of novel agents for the treatment of hepatitis C virus.
    Hepatology. 2008;.
    PubMed     Related articles   
    
    
    
21. JONSSON JR , Barrie HD, O'Rourke P, Clouston AD, et al
    Obesity and steatosis influence serum and hepatic inflammatory markers in chronic hepatitis C.
    Hepatology. 2008;48:80-87.
    PubMed     Related articles    Abstract available
    
    
    
22. LEE SH , Song R, Lee MN, Kim CS, et al
    A molecular chaperone glucose-regulated protein 94 blocks apoptosis induced by virus infection.
    Hepatology. 2008;47:854-66.
    PubMed     Related articles    Abstract available
    
    
    February 2008
23. ZEISEL MB , Cosset FL, Baumert TF
    Host neutralizing responses and pathogenesis of hepatitis C virus infection.
    Hepatology. 2008;.
    PubMed     Related articles   
    
    
    
24. BORTOLAMI M , Cardin R, Kotsafti A, Farinati F, et al
    TGF-beta and hepatocellular carcinoma.
    Hepatology. 2008;47:1095.
    PubMed     Related articles   
    
    
    
25. HIASA Y , Kuzuhara H, Tokumoto Y, Konishi I, et al
    Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
26. BEARD MR , Helbig KJ
    Control of HCV replication: When size does not matter.
    Hepatology. 2008;47:1092-1094.
    PubMed     Related articles   
    
    
    
27. SHEIKH MY , Choi J, Qadri I, Friedman JE, et al
    Hepatitis C virus infection: Molecular pathways to metabolic syndrome.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
28. FERENCI P , Brunner H, Laferl H, Scherzer TM, et al
    A randomized, prospective trial of ribavirin 400 mg/day versus 800 mg/day in combination with peginterferon alfa-2a in hepatitis C virus genotypes 2 and 3.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
29. LAGGING M , Langeland N, Pedersen C, Farkkila M, et al
    Randomized comparison of 12 or 24 weeks of peginterferon alpha-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
30. VELDT BJ , Chen W, Heathcote EJ, Wedemeyer H, et al
    Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus.
    Hepatology. 2008;47:1856-1862.
    PubMed     Related articles    Abstract available
    
    
    January 2008
31. VANWOLLEGHEM T , Bukh J, Meuleman P, Desombere I, et al
    Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver-chimeric mice from infection with a homologous hepatitis C virus strain.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
32. NEUMANN-HAEFELIN C , Timm J, Spangenberg HC, Wischniowski N, et al
    Virological and immunological determinants of intrahepatic virus-specific CD8+ T-cell failure in chronic hepatitis C virus infection.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
33. KAMAL SM , Nasser IA
    Hepatitis C genotype 4: What we know and what we don't yet know.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
34. HSU CS , Kao JH
    Insulin resistance, adipocytokines, and hepatitis C virus infection: A missing link?
    Hepatology. 2008;47:760-761.
    PubMed     Related articles   
    
    
    
35. ADLER M , Gulbis B, Moreno C, Evrard S, et al
    The predictive value of FIB-4 versus FibroTest, APRI, FibroIndex and Forns index to noninvasively estimate fibrosis in hepatitis C and nonhepatitis C liver diseases.
    Hepatology. 2008;47:762-763.
    PubMed     Related articles   
    
    
    
36. VALLET-PICHARD A , Mallet V, Pol S
    Predictive value of FIB-4 versus fibrotest, APRI, FIBROINDEX and FORNS to noninvasively estimate fibrosis in hepatitis C.
    Hepatology. 2008;47:763.
    PubMed     Related articles   
    
    
    
37. COLSON P , Brouk N, Lembo F, Castellani P, et al
    Natural presence of substitution R155K within hepatitis C virus NS3 protease from a treatment-naive chronically infected patient.
    Hepatology. 2008;47:766-767.
    PubMed     Related articles   
    
    
    
38. LAU DT , Fish PM, Sinha M, Owen DM, et al
    Interferon regulatory factor-3 activation, hepatic interferon-stimulated gene expression, and immune cell infiltration in hepatitis C virus patients.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
39. TRUJILLO-MURILLO K , Rincon-Sanchez AR, Martinez-Rodriguez H, Bosques-Padilla F, et al
    Acetylsalicylic acid inhibits hepatitis C virus RNA and protein expression through cyclooxygenase 2 signaling pathways.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
40. LOUSTAUD-RATTI V , Alain S, Rousseau A, Hubert IF, et al
    Ribavirin exposure after the first dose is predictive of sustained virological response in chronic hepatitis C.
    Hepatology. 2008;47:1453-1461.
    PubMed     Related articles    Abstract available
    
    
    
41. NORTHFIELD JW , Kasprowicz V, Lucas M, Kersting N, et al
    CD161 expression on hepatitis C virus-specific CD8+ T cells suggests a distinct pathway of T cell differentiation.
    Hepatology. 2008;47:396-406.
    PubMed     Related articles    Abstract available
    
    
    
42. FLISIAK R , Horban A, Gallay P, Bobardt M, et al
    The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus.
    Hepatology. 2008;47:817-826.
    PubMed     Related articles    Abstract available
    
    
    
43. NAHMIAS Y , Goldwasser J, Casali M, van Poll D, et al
    Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
44. STERLING RK , Contos MJ, Smith PG, Stravitz RT, et al
    Steatohepatitis: Risk factors and impact on disease severity in human immunodeficiency virus/hepatitis C virus coinfection.
    Hepatology. 2008;47:1118-1127.
    PubMed     Related articles    Abstract available
    
    
    
45. FONTANA RJ , Goodman ZD, Dienstag JL, Bonkovsky HL, et al
    Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
46. CHUNG RT , Gale M Jr, Polyak SJ, Lemon SM, et al
    Mechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop.
    Hepatology. 2008;47:306-20.
    PubMed     Related articles   
    
    
    
47. SANGIOVANNI A , Iavarone M
    Hepatitis C virus genotype 1b, cirrhosis, and risk of hepatocellular carcinoma.
    Hepatology. 2008;47:357.
    PubMed     Related articles   
    
    
    
48. WOLK B , Wedemeyer H
    Hepatitis C virus living off the fat of the land.
    Hepatology. 2008;47:343-5.
    PubMed     Related articles   
    
    
    
49. RILEY TR 3RD
    Predictors of response of U.S. veterans to treatment for the hepatitis C virus.
    Hepatology. 2008;47:356.
    PubMed     Related articles   
    
    
    
50. MORRA R , Lebray P, Ingiliz P, Ngo Y, et al
    FibroTest has better diagnostic and prognostic values than the aspartate aminotransferase-to-platelet ratio index in patients with chronic hepatitis C.
    Hepatology. 2008;47:353-4.
    PubMed     Related articles   
    
    
    
51. BLACKARD JT , Shata MT, Shire NJ, Sherman KE, et al
    Acute hepatitis C virus infection: a chronic problem.
    Hepatology. 2008;47:321-31.
    PubMed     Related articles   
    
    
    
52. KUROSAKI M , Izumi N
    External validation of FIB-4: diagnostic accuracy is limited in elderly populations.
    Hepatology. 2008;47:352.
    PubMed     Related articles   
    
    
    December 2007
53. GOODMAN ZD , Makhlouf HR, Liu L, Balistreri W, et al
    Pathology of chronic hepatitis C in children: Liver biopsy findings in the Peds-C Trial.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
54. SEEFF LB , Curto TM, Szabo G, Everson GT, et al
    Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
55. ROMERO-GOMEZ M , Gomez-Gonzalez E, Madrazo A, Vera-Valencia M, et al
    Optical analysis of computed tomography images of the liver predicts fibrosis stage and distribution in chronic hepatitis C.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
56. DUCLOS-VALLEE JC , Feray C, Sebagh M, Teicher E, et al
    Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
57. BERNARDIN F , Tobler L, Walsh I, Williams JD, et al
    Clearance of hepatitis C virus RNA from the peripheral blood mononuclear cells of blood donors who spontaneously or therapeutically control their plasma viremia.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
58. DHAREL N , Kato N, Muroyama R, Taniguchi H, et al
    Potential contribution of tumor suppressor p53 in the host defense against hepatitis C virus.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
59. VARNHOLT H , Drebber U, Schulze F, Wedemeyer I, et al
    MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
60. WISE M , Bialek S, Finelli L, Bell BP, et al
    Changing trends in hepatitis C-related mortality in the United States, 1995-2004.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
61. YU ML , Dai CY, Huang JF, Hsieh MY, et al
    Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: Some issues.
    Hepatology. 2007;47:1792-1793.
    PubMed     Related articles   
    
    
    
62. DAI CY , Chuang WL, Huang JF, Hsieh MY, et al
    Possible determinants of rapid virological response suggesting shorter courses of combination therapy for hepatitis C virus genotype 2.
    Hepatology. 2007;.
    PubMed     Related articles   
    
    
    
63. EINAV S , Sklan EH, Moon HM, Gehrig E, et al
    The nucleotide binding motif of hepatitis C virus NS4B can mediate cellular transformation and tumor formation without Ha-ras co-transfection.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
64. REYNOLDS GM , Harris HJ, Jennings A, Hu K, et al
    Hepatitis C virus receptor expression in normal and diseased liver tissue.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
65. LIAO G , Wang Y, Chang J, Bian T, et al
    Hepatitis B virus precore protein augments genetic immunizations of the truncated hepatitis C virus core in BALB/c mice.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
66. MANGIA A , Minerva N, Bacca D, Cozzolongo R, et al
    Individualized treatment duration for hepatitis C genotype 1 patients: A randomized controlled trial.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
67. CHAVEZ-TAPIA NC , Tellez-Avila FI
    Nonalcoholic steatohepatitis in chronic hepatitis C: A new classification?
    Hepatology. 2007;.
    PubMed     Related articles   
    
    
    
68. SHIINA M , Rehermann B
    Cell culture-produced hepatitis C virus impairs plasmacytoid dendritic cell function.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
69. HOEFS JC , Morgan TR
    Seventy-two weeks of peginterferon and ribavirin for patients with partial early virologic response?
    Hepatology. 2007;46:1671-4.
    PubMed     Related articles   
    
    
    
70. VAN DER POORTEN D , Kenny DT, Butler T, George J, et al
    Liver disease in adolescents: A cohort study of high-risk individuals.
    Hepatology. 2007;46:1750-8.
    PubMed     Related articles    Abstract available
    
    
    November 2007
71. PEARLMAN BL , Ehleben C, Saifee S
    Treatment extension to 72 weeks of peginterferon and ribavirin in hepatitis c genotype 1-infected slow responders.
    Hepatology. 2007;46:1688-1694.
    PubMed     Related articles    Abstract available
    
    
    
72. TSOCHATZIS E , Papatheodoridis GV, Archimandritis AJ
    Adipokines and insulin resistance in chronic hepatitis C.
    Hepatology. 2007;46:2050-2051.
    PubMed     Related articles   
    
    
    
73. KANWAL F , Hoang T, Spiegel BM, Eisen S, et al
    Predictors of treatment in patients with chronic hepatitis C infection-Role of patient versus nonpatient factors.
    Hepatology. 2007;46:1741-1749.
    PubMed     Related articles    Abstract available
    
    
    
74. SHERMAN KE , Fleischer R, Laessig K, Murray J, et al
    Development of novel agents for the treatment of chronic hepatitis C infection: Summary of the FDA Antiviral Products Advisory Committee recommendations.
    Hepatology. 2007;.
    PubMed     Related articles   
    
    
    
75. ZEISEL MB , Koutsoudakis G, Schnober EK, Haberstroh A, et al
    Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
76. DALGARD O , Bjoro K, Ring-Larsen H, Bjornsson E, et al
    Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
77. MALHI H
    TRAILs and tribulation.
    Hepatology. 2007;46:1320-2.
    PubMed     Related articles   
    
    
    October 2007
78. PAPPAS SC
    Good science behind hepatitis C virus antiviral drug development: Necessary but not sufficient.
    Hepatology. 2007;46:1317-1318.
    PubMed     Related articles   
    
    
    
79. SHACKEL NA , McCaughan GW
    Intrahepatic interferon-stimulated gene responses: Can they predict treatment responses in chronic hepatitis C infection?
    Hepatology. 2007;46:1326-1328.
    PubMed     Related articles   
    
    
    
80. KAMAL SM , El Kamary SS, Shardell MD, Hashem M, et al
    Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: The role of rapid and early virologic response.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
81. TIMPE JM , Stamataki Z, Jennings A, Hu K, et al
    Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
82. INOUE K , Watanabe T, Yoshiba M, Kohara M, et al
    Hepatitis C virus RNA kinetics in chimeric mice with human hepatocytes during antiviral therapy.
    Hepatology. 2007;.
    PubMed     Related articles   
    
    
    
83. SOBESKY R , Feray C, Rimlinger F, Derian N, et al
    Distinct hepatitis C virus core and F protein quasispecies in tumoral and nontumoral hepatocytes isolated via microdissection.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
84. HRABER P , Kuiken C, Yusim K
    Evidence for human leukocyte antigen heterozygote advantage against hepatitis C virus infection.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
85. DAHARI H , Perelson AS
    Hepatitis C virus kinetics in chimeric mice during antiviral therapy.
    Hepatology. 2007;.
    PubMed     Related articles   
    
    
    
86. MCHUTCHISON JG , Bacon BR, Gordon SC, Lawitz E, et al
    Phase 1B, randomized, double-blind, dose-escalation trial of CPG 10101 in patients with chronic hepatitis C virus.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
87. FELD JJ , Nanda S, Huang Y, Chen W, et al
    Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
88. SMITH J , Han SH
    "True" weight-based dosing versus "flat" dosing of ribavirin: will the WIN-R please come forward?
    Hepatology. 2007;46:953-6.
    PubMed     Related articles   
    
    
    September 2007
89. JACOBSON IM , Brown RS Jr, McCone J, Black M, et al
    Impact of weight-based ribavirin with peginterferon alfa-2b in african americans with hepatitis C virus genotype 1.
    Hepatology. 2007;46:982-990.
    PubMed     Related articles    Abstract available
    
    
    
90. WORMAN HJ
    Re-evaluating the use of growth factors as adjuvant treatment of chronic hepatitis C.
    Hepatology. 2007;46:1307-1308.
    PubMed     Related articles    Abstract available
    
    
    
91. JACOBSON IM , Brown RS Jr, Freilich B, Afdhal N, et al
    Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: A randomized trial.
    Hepatology. 2007;46:971-981.
    PubMed     Related articles    Abstract available
    
    
    
92. SZABO G , Chang S, Dolganiuc A
    Altered innate immunity in chronic hepatitis C infection: Cause or effect?
    Hepatology. 2007;.
    PubMed     Related articles   
    
    
    
93. GEPPERT CM , Arora S
    Widening the door: The evolution of hepatitis C treatment in patients with psychiatric disorders.
    Hepatology. 2007;.
    PubMed     Related articles   
    
    
    
94. FORESTIER N , Reesink HW, Weegink CJ, McNair L, et al
    Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis C.
    Hepatology. 2007;46:640-8.
    PubMed     Related articles    Abstract available
    
    
    
95. MODI AA , Hoofnagle JH
    New therapies for hepatitis C.
    Hepatology. 2007;46:615-7.
    PubMed     Related articles   
    
    
    
96. GARCIA-SAMANIEGO J , Forns X
    Hepatitis C virus and human immunodeficiency virus: The Un-Won Battle.
    Hepatology. 2007;46:611-4.
    PubMed     Related articles   
    
    
    August 2007
97. SHAHEEN AA , Myers RP
    Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: A systematic review.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
98. NOVICK DM , Kreek MJ
    Hepatitis C treatment, subcutaneous naltrexone implants, and methadone maintenance treatment.
    Hepatology. 2007;.
    PubMed     Related articles   
    
    
    
99. VOLKMANN X , Fischer U, Bahr MJ, Ott M, et al
    Increased hepatotoxicity of tumor necrosis factor-related apoptosis-inducing ligand in diseased human liver.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
100. KIEFFER TL , Sarrazin C, Miller JS, Welker MW, et al
     Telaprevir and pegylated interferon-alpha-2a inhibit wild-type and resistant genotype 1 hepatitis C virus replication in patients.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
101. BRUNO S , Crosignani A, Maisonneuve P, Rossi S, et al
     Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: A seventeen-year prospective cohort study.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
102. BONORINO P , Leroy V, Dufeu-Duchesne T, Tongiani-Dashan S, et al
     Features and distribution of CD8 T cells with human leukocyte antigen class I-specific receptor expression in chronic hepatitis C.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
103. NATTERMANN J , Vogel M, Berg T, Danta M, et al
     Effect of the interleukin-6 C174G gene polymorphism on treatment of acute and chronic hepatitis C in human immunodeficiency virus coinfected patients.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
104. SCHAEFER M , Hinzpeter A, Mohmand A, Janssen G, et al
     Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: Response and psychiatric side effects.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
105. BINDER M , Kochs G, Bartenschlager R, Lohmann V, et al
     Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
106. PERSICO M , Capasso M, Persico E, Svelto M, et al
     Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: Insulin resistance and response to antiviral therapy.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
107. LANFORD RE , Guerra B, Bigger CB, Lee H, et al
     Lack of response to exogenous interferon-alpha in the liver of chimpanzees chronically infected with hepatitis C virus.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
108. LASKUS T , Wilkinson J, Karim R, Mack W, et al
     Hepatitis C virus quasispecies in HIV-infected women: Role of injecting drug use and highly active antiretroviral therapy (HAART).
     Hepatology. 2007;46:359-70.
     PubMed     Related articles    Abstract available
     
     
     
109. BEDOSSA P , Moucari R, Chelbi E, Asselah T, et al
     Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: A prospective study.
     Hepatology. 2007;46:380-7.
     PubMed     Related articles    Abstract available
     
     
     
110. ROSEN HR , Weston SJ, Im K, Yang H, et al
     Selective decrease in hepatitis C virus-specific immunity among African Americans and outcome of antiviral therapy.
     Hepatology. 2007;46:350-8.
     PubMed     Related articles    Abstract available
     
     
     July 2007
111. LEWIN M , Poujol-Robert A, Boelle PY, Wendum D, et al
     Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
112. TSENG FC , O'brien TR, Zhang M, Kral AH, et al
     Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
113. AKUTA N , Suzuki F, Kawamura Y, Yatsuji H, et al
     Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
114. DIAMOND DL , Jacobs JM, Paeper B, Proll SC, et al
     Proteomic profiling of human liver biopsies: Hepatitis C virus-induced fibrosis and mitochondrial dysfunction.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
115. POCKROS PJ , Schiff ER, Shiffman ML, McHutchison JG, et al
     Oral IDN-6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis C.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
116. CHAN HL , Ren H, Chow WC, Wee T, et al
     Randomized trial of interferon beta-1a with or without ribavirin in Asian patients with chronic hepatitis C.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
117. PINEDA JA , Garcia-Garcia JA, Aguilar-Guisado M, Rios-Villegas MJ, et al
     Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
118. SCHIAVON LL , Schiavon JL, Carvalho Filho RJ, Sampaio JP, et al
     Simple blood tests as noninvasive markers of liver fibrosis in hemodialysis patients with chronic hepatitis C virus infection.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
119. HALFON P , Penaranda G, Renou C, Bourliere M, et al
     External validation of FibroIndex.
     Hepatology. 2007;46:280-1.
     PubMed     Related articles   
     
     
     June 2007
120. FERNANDES F , Poole DS, Hoover S, Middleton R, et al
     Sensitivity of hepatitis C virus to cyclosporine A depends on nonstructural proteins NS5A and NS5B.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
121. STEINMANN E , Whitfield T, Kallis S, Dwek RA, et al
     Antiviral effects of amantadine and iminosugar derivatives against hepatitis C virus.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
122. WU WK , Duh MS, Lefebvre P
     Is there a difference in the cost-effectiveness of erythropoietic therapies for the treatment of anemia in patients receiving HCV combination therapy?
     Hepatology. 2007;46:283.
     PubMed     Related articles   
     
     
     
123. BEARD MR , Warner FJ
     Claudin-1, a new junction in the hepatitis C virus entry pathway.
     Hepatology. 2007;46:277-279.
     PubMed     Related articles   
     
     
     
124. MATSUZAKI K , Murata M, Yoshida K, Sekimoto G, et al
     Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma.
     Hepatology. 2007;46:48-57.
     PubMed     Related articles    Abstract available
     
     
     
125. CUA IH , Hui JM, Bandara P, Kench JG, et al
     Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines.
     Hepatology. 2007;46:66-73.
     PubMed     Related articles    Abstract available
     
     
     
126. DAHARI H , Ribeiro RM, Perelson AS
     Triphasic decline of hepatitis C virus RNA during antiviral therapy.
     Hepatology. 2007;46:16-21.
     PubMed     Related articles    Abstract available
     
     
     
127. PICCOLI C , Scrima R, Quarato G, D'Aprile A, et al
     Hepatitis C virus protein expression causes calcium-mediated mitochondrial bioenergetic dysfunction and nitro-oxidative stress.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
128. BACKUS LI , Boothroyd DB, Phillips BR, Mole LA, et al
     Predictors of response of U.S. veterans to treatment for the hepatitis C virus.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
129. VALLET-PICHARD A , Mallet V, Nalpas B, Verkarre V, et al
     FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
130. SHIFFMAN ML , Salvatore J, Hubbard S, Price A, et al
     Treatment of chronic hepatitis C virus genotype 1 with peginterferon, ribavirin, and epoetin alpha.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
131. TIMM J , Li B, Daniels MG, Bhattacharya T, et al
     Human leukocyte antigen-associated sequence polymorphisms in hepatitis C virus reveal reproducible immune responses and constraints on viral evolution.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     May 2007
132. WERTHEIMER AM , Polyak SJ, Leistikow R, Rosen HR, et al
     Engulfment of apoptotic cells expressing HCV proteins leads to differential chemokine expression and STAT signaling in human dendritic cells.
     Hepatology. 2007;45:1422-1432.
     PubMed     Related articles    Abstract available
     
     
     
133. SU TH , Kao JH, Chen DS
     APRI-M6 for predicting long-term outcome of chronic hepatitis C patients after interferon-based therapy: More questions than answers.
     Hepatology. 2007;45:1586-1587.
     PubMed     Related articles   
     
     
     
134. YEE LJ , Tang YM, Kleiner DE, Wang D, et al
     Myxovirus-1 and protein kinase haplotypes and fibrosis in chronic hepatitis C virus.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
135. CHEVALIEZ S , Bouvier-Alias M, Brillet R, Pawlotsky JM, et al
     Overestimation and underestimation of hepatitis C virus RNA levels in a widely used real-time polymerase chain reaction-based method.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
136. NG TI , Mo H, Pilot-Matias T, He Y, et al
     Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
137. PAZIENZA V , Clement S, Pugnale P, Conzelman S, et al
     The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms.
     Hepatology. 2007;45:1164-71.
     PubMed     Related articles    Abstract available
     
     
     
138. FONTANA RJ , Bieliauskas LA, Lindsay KL, Back-Madruga C, et al
     Cognitive function does not worsen during pegylated interferon and ribavirin retreatment of chronic hepatitis C.
     Hepatology. 2007;45:1154-63.
     PubMed     Related articles    Abstract available
     
     
     
139. WESTIN J , Hellstrand K, Alsio A, Ydreborg M, et al
     Impact of disease severity on outcome of antiviral therapy in treatment-naive patients with chronic hepatitis C.
     Hepatology. 2007;45:1333-4.
     PubMed     Related articles   
     
     
     
140. DORE GJ , Micallef J
     Low incidence of HCV reinfection: Exposure, testing frequency, or protective immunity?
     Hepatology. 2007;45:1330.
     PubMed     Related articles   
     
     
     
141. VIZZUTTI F , Arena U, Romanelli RG, Rega L, et al
     Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis.
     Hepatology. 2007;45:1290-7.
     PubMed     Related articles    Abstract available
     
     
     April 2007
142. HUANG H , Shiffman ML, Friedman S, Venkatesh R, et al
     A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
143. KANMURA S , Uto H, Kusumoto K, Ishida Y, et al
     Early diagnostic potential for hepatocellular carcinoma using the SELDI ProteinChip system.
     Hepatology. 2007;45:948-56.
     PubMed     Related articles    Abstract available
     
     
     March 2007
144. GOODMAN ZD , Becker RL Jr, Pockros PJ, Afdhal NH, et al
     Progression of fibrosis in advanced chronic hepatitis C: Evaluation by morphometric image analysis.
     Hepatology. 2007;45:886-894.
     PubMed     Related articles    Abstract available
     
     
     
145. WURMBACH E , Chen YB, Khitrov G, Zhang W, et al
     Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma.
     Hepatology. 2007;45:938-947.
     PubMed     Related articles    Abstract available
     
     
     
146. INOUE K , Umehara T, Ruegg UT, Yasui F, et al
     Evaluation of a cyclophilin inhibitor in hepatitis C virus-infected chimeric mice in vivo.
     Hepatology. 2007;45:921-928.
     PubMed     Related articles    Abstract available
     
     
     
147. O'LEARY JG , Chan JL, McMahon CM, Chung RT, et al
     Atorvastatin does not exhibit antiviral activity against HCV at conventional doses: A pilot clinical trial.
     Hepatology. 2007;45:895-898.
     PubMed     Related articles    Abstract available
     
     
     
148. TORRESI J , Stock OM, Fischer AE, Grollo L, et al
     A self-adjuvanting multiepitope immunogen that induces a broadly cross-reactive antibody to hepatitis C virus.
     Hepatology. 2007;45:911-920.
     PubMed     Related articles    Abstract available
     
     
     
149. FRANCO S , Parera M, Aparicio E, Clotet B, et al
     Genetic and catalytic efficiency structure of an HCV protease quasispecies.
     Hepatology. 2007;45:899-910.
     PubMed     Related articles    Abstract available
     
     
     February 2007
150. BRUNO S , Stroffolini T, Colombo M, Bollani S, et al
     Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: A retrospective study.
     Hepatology. 2007;45:579-587.
     PubMed     Related articles    Abstract available
     
     
     
151. YOUNOSSI Z , Kallman J, Kincaid J
     The effects of HCV infection and management on health-related quality of life.
     Hepatology. 2007;45:806-816.
     PubMed     Related articles    Abstract available
     
     
     
152. ABORSANGAYA KB , Dembinski I, Khatkar S, Alphonse MP, et al
     Impact of aboriginal ethnicity on HCV core-induced IL-10 synthesis: Interaction with IL-10 gene polymorphisms.
     Hepatology. 2007;45:623-630.
     PubMed     Related articles    Abstract available
     
     
     
153. ROLLIER CS , Paranhos-Baccala G, Verschoor EJ, Verstrepen BE, et al
     Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity.
     Hepatology. 2007;45:602-613.
     PubMed     Related articles    Abstract available
     
     
     
154. PENNA A , Pilli M, Zerbini A, Orlandini A, et al
     Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection.
     Hepatology. 2007;45:588-601.
     PubMed     Related articles    Abstract available
     
     
     
155. POCKROS PJ , Jeffers L, Afdhal N, Goodman ZD, et al
     Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gamma1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis.
     Hepatology. 2007;45:569-578.
     PubMed     Related articles    Abstract available
     
     
     January 2007
156. KODA M , Matunaga Y, Kawakami M, Kishimoto Y, et al
     Fibroindex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C.
     Hepatology. 2007;45:297-306.
     PubMed     Related articles    Abstract available
     
     
     
157. THEVENOT T , Cadranel JF, Di Martino V, Pariente A, et al
     A national French survey on the use of growth factors as adjuvant treatment of chronic hepatitis C.
     Hepatology. 2007;45:377-383.
     PubMed     Related articles    Abstract available
     
     
     
158. JEFFREY GP , Macquillan G, Chua F, Galhenage S, et al
     Hepatitis C virus eradication in intravenous drug users maintained with subcutaneous naltrexone implants.
     Hepatology. 2007;45:111-7.
     PubMed     Related articles    Abstract available
     
     
     
159. DORE GJ
     Enhancing hepatitis C treatment uptake and outcomes for injection drug users.
     Hepatology. 2007;45:3-5.
     PubMed     Related articles   
     
     
     
160. SCHIAVON LL , Filho RJ, Narciso JL, Sampaio JP, et al
     Expanding the applicability of noninvasive fibrosis markers in HIV/HCV co-infected patients.
     Hepatology. 2007;45:257-8.
     PubMed     Related articles   
     
     
     
161. LUKASIEWICZ E , Hellstrand K, Westin J, Ferrari C, et al
     Predicting treatment outcome following 24 weeks peginterferon alpha-2a/ribavirin therapy in patients infected with HCV genotype 1: Utility of HCV-RNA at day 0, day 22, day 29, and week 6.
     Hepatology. 2007;45:258-9.
     PubMed     Related articles   
     
     
     
162. LONARDO A , Loria P, Bertolotti M, Carulli N, et al
     Statins and HCV: A complex issue.
     Hepatology. 2007;45:257.
     PubMed     Related articles   
     
     
     
163. CONJEEVARAM HS , Kleiner DE, Everhart JE, Hoofnagle JH, et al
     Race, insulin resistance and hepatic steatosis in chronic hepatitis C.
     Hepatology. 2007;45:80-7.
     PubMed     Related articles    Abstract available
     
     
     November 2006
164. EVERSON GT , Hoefs JC, Seeff LB, Bonkovsky HL, et al
     Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial.
     Hepatology. 2006;44:1675-1684.
     PubMed     Related articles    Abstract available
     
     
     
165. VILASCO M , Larrea E, Vitour D, Dabo S, et al
     The protein kinase IKKepsilon can inhibit HCV expression independently of IFN and its own expression is downregulated in HCV-infected livers.
     Hepatology. 2006;44:1635-1647.
     PubMed     Related articles    Abstract available
     
     
     
166. BELLECAVE P , Moradpour D
     A picture says more than a thousand words: Structural insights into hepatitis C virus translation initiation.
     Hepatology. 2006;44:1687-1690.
     PubMed     Related articles    Abstract available
     
     
     
167. MAZZAFERRO V , Romito R, Schiavo M, Mariani L, et al
     Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis.
     Hepatology. 2006;44:1543-1554.
     PubMed     Related articles    Abstract available
     
     
     
168. ABEL M , Sene D, Pol S, Bourliere M, et al
     Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection.
     Hepatology. 2006;44:1607-1616.
     PubMed     Related articles    Abstract available
     
     
     
169. DEL RIO RA , Post AB, Singer ME
     Cost-effectiveness of hematologic growth factors for anemia occurring during hepatitis C combination therapy.
     Hepatology. 2006;44:1598-1606.
     PubMed     Related articles    Abstract available
     
     
     
170. GOUTTENOIRE J , Moradpour D, Penin F
     Surprises from the crystal structure of the hepatitis C virus NS2-3 protease.
     Hepatology. 2006;44:1690-1693.
     PubMed     Related articles    Abstract available
     
     
     
171. BUGIANESI E , Marchesini G, Gentilcore E, Cua IH, et al
     Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
     Hepatology. 2006;44:1648-1655.
     PubMed     Related articles    Abstract available
     
     
     
172. LAVIE M , Voisset C, Vu-Dac N, Zurawski V, et al
     Serum amyloid A has antiviral activity against hepatitis C virus by inhibiting virus entry in a cell culture system.
     Hepatology. 2006;44:1626-1634.
     PubMed     Related articles    Abstract available
     
     
     
173. LAGGING M , Romero AI, Westin J, Norkrans G, et al
     IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection.
     Hepatology. 2006;44:1617-1625.
     PubMed     Related articles    Abstract available
     
     
     
174. MUIR AJ , McHutchison JG
     Growth factors during HCV therapy may be "cost-effective", but are they "effective"?
     Hepatology. 2006;44:1400-1403.
     PubMed     Related articles   
     
     
     
175. GOLDEN-MASON L , Burton JR Jr, Castelblanco N, Klarquist J, et al
     Loss of IL-7 receptor alpha-chain (CD127) expression in acute HCV infection associated with viral persistence.
     Hepatology. 2006;44:1098-109.
     PubMed     Related articles    Abstract available
     
     
     
176. SHIRE NJ , Horn PS, Rouster SD, Stanford S, et al
     HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia.
     Hepatology. 2006;44:1146-57.
     PubMed     Related articles    Abstract available
     
     
     
177. YU ML , Lin SM, Lee CM, Dai CY, et al
     A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy.
     Hepatology. 2006;44:1086-97.
     PubMed     Related articles    Abstract available
     
     
     
178. KUIKEN C , Combet C, Bukh J, Shin-I T, et al
     A comprehensive system for consistent numbering of HCV sequences, proteins and epitopes.
     Hepatology. 2006;44:1355-1361.
     PubMed     Related articles    Abstract available
     
     
     
179. GREBELY J , Conway B, Raffa JD, Lai C, et al
     Hepatitis C virus reinfection in injection drug users.
     Hepatology. 2006;44:1139-45.
     PubMed     Related articles    Abstract available
     
     
     
180. HONDA M , Yamashita T, Ueda T, Takatori H, et al
     Different signaling pathways in the livers of patients with chronic hepatitis B or chronic hepatitis C.
     Hepatology. 2006;44:1122-38.
     PubMed     Related articles    Abstract available
     
     
     
181. SHNEIDER BL , Gonzalez-Peralta R, Roberts EA
     Controversies in the management of pediatric liver disease: Hepatitis B, C and NAFLD: Summary of a single topic conference.
     Hepatology. 2006;44:1344-54.
     PubMed     Related articles   
     
     
     September 2006
182. WEDEMEYER H , Cornberg M, Wiegand J, Manns M, et al
     Treatment duration in acute hepatitis C: The issue is not solved yet.
     Hepatology. 2006;44:1051.
     PubMed     Related articles   
     
     
     
183. KAWAMURA H , Govindarajan S, Aswad F, Machida K, et al
     HCV core expression in hepatocytes protects against autoimmune liver injury and promotes liver regeneration in mice.
     Hepatology. 2006;44:936-944.
     PubMed     Related articles    Abstract available
     
     
     
184. FONTANA RJ , Kleiner DE, Bilonick R, Terrault N, et al
     Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infection.
     Hepatology. 2006;44:925-935.
     PubMed     Related articles    Abstract available
     
     
     
185. NATTERMANN J , Zimmermann H, Iwan A, von Lilienfeld-Toal M, et al
     Hepatitis C virus E2 and CD81 interaction may be associated with altered trafficking of dendritic cells in chronic hepatitis C.
     Hepatology. 2006;44:945-954.
     PubMed     Related articles    Abstract available
     
     
     August 2006
186. PUIG M , Mihalik K, Tilton JC, Williams O, et al
     CD4+ immune escape and subsequent T-cell failure following chimpanzee immunization against hepatitis C virus.
     Hepatology. 2006;44:736-745.
     PubMed     Related articles    Abstract available
     
     
     
187. BARTH H , Liang TJ, Baumert TF
     Hepatitis C virus entry: Molecular biology and clinical implications.
     Hepatology. 2006;44:527-535.
     PubMed     Related articles    Abstract available
     
     
     
188. VALLET-PICHARD A , Mallet V, Pol S
     FIB-4: A simple, inexpensive and accurate marker of fibrosis in HCV-infected patients.
     Hepatology. 2006;44:769.
     PubMed     Related articles   
     
     
     July 2006
189. HE XS , Ji X, Hale MB, Cheung R, et al
     Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race.
     Hepatology. 2006;44:352-359.
     PubMed     Related articles    Abstract available
     
     
     
190. HWANG LY , Kramer JR, Troisi C, Bull L, et al
     Relationship of cosmetic procedures and drug use to hepatitis C and hepatitis B virus infections in a low-risk population.
     Hepatology. 2006;44:341-351.
     PubMed     Related articles    Abstract available
     
     
     
191. MORISHIMA C , Morgan TR, Everhart JE, Wright EC, et al
     HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial.
     Hepatology. 2006;44:360-367.
     PubMed     Related articles    Abstract available
     
     
     
192. GOPAL K , Johnson TC, Gopal S, Walfish A, et al
     Correlation between beta-lipoprotein levels and outcome of hepatitis C treatment.
     Hepatology. 2006;44:335-340.
     PubMed     Related articles    Abstract available
     
     
     
193. DE ROSA F , Cariti G, Di Perri G
     Acute hepatitis C: Dosage and compliance.
     Hepatology. 2006;44:511.
     PubMed     Related articles   
     
     
     
194. CARULLI L , Lonardo A, Lombardini S, Marchesini G, et al
     Gender, fatty liver and GGT.
     Hepatology. 2006;44:278-9.
     PubMed     Related articles   
     
     
     June 2006
195. URBANI S , Amadei B, Fisicaro P, Tola D, et al
     Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses.
     Hepatology. 2006;44:126-139.
     PubMed     Related articles    Abstract available
     
     
     
196. BLACKARD JT , Kemmer N, Sherman KE
     Extrahepatic replication of HCV: Insights into clinical manifestations and biological consequences.
     Hepatology. 2006;44:15-22.
     PubMed     Related articles    Abstract available
     
     
     
197. IKEDA M , Abe KI, Yamada M, Dansako H, et al
     Different anti-HCV profiles of statins and their potential for combination therapy with interferon.
     Hepatology. 2006;44:117-125.
     PubMed     Related articles    Abstract available
     
     
     May 2006
198. CHARLTON MR , Pockros PJ, Harrison SA
     Impact of obesity on treatment of chronic hepatitis C.
     Hepatology. 2006;43:1177-1186.
     PubMed     Related articles    Abstract available
     
     
     
199. SHIINA M , Rehermann B
     Hepatitis C vaccines: Inducing and challenging memory T cells.
     Hepatology. 2006;43:1395-1398.
     PubMed     Related articles    Abstract available
     
     
     
200. KNETEMAN NM , Weiner AJ, O'connell J, Collett M, et al
     Anti-HCV therapies in chimeric scid-Alb/uPA mice parallel outcomes in human clinical application.
     Hepatology. 2006;43:1346-1353.
     PubMed     Related articles    Abstract available
     
     
     
201. SAADOUN D , Asselah T, Resche-Rigon M, Charlotte F, et al
     Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C.
     Hepatology. 2006;43:1337-1345.
     PubMed     Related articles    Abstract available
     
     
     
202. FRICK DN
     Step-by-step progress toward understanding the hepatitis C virus RNA helicase.
     Hepatology. 2006;43:1392-1395.
     PubMed     Related articles    Abstract available
     
     
     
203. STRNAD P , Lienau TC, Tao GZ, Lazzeroni LC, et al
     Keratin variants associate with progression of fibrosis during chronic hepatitis C infection.
     Hepatology. 2006;43:1354-1363.
     PubMed     Related articles    Abstract available
     
     
     
204. FANG X , Zeisel MB, Wilpert J, Gissler B, et al
     Host cell responses induced by hepatitis C virus binding.
     Hepatology. 2006;43:1326-1336.
     PubMed     Related articles    Abstract available
     
     
     
205. STERLING RK , Lissen E, Clumeck N, Sola R, et al
     Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection.
     Hepatology. 2006;43:1317-1325.
     PubMed     Related articles    Abstract available
     
     
     
206. VOLKMANN X , Cornberg M, Wedemeyer H, Lehner F, et al
     Caspase activation is required for antiviral treatment response in chronic hepatitis C virus infection.
     Hepatology. 2006;43:1311-1316.
     PubMed     Related articles    Abstract available
     
     
     
207. SANGIOVANNI A , Prati GM, Fasani P, Ronchi G, et al
     The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients.
     Hepatology. 2006;43:1303-1310.
     PubMed     Related articles    Abstract available
     
     
     
208. LAI MS , Hsieh MS, Chiu YH, Chen TH, et al
     Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection.
     Hepatology. 2006;43:1295-1302.
     PubMed     Related articles    Abstract available
     
     
     
209. TALAL AH , Ribeiro RM, Powers KA, Grace M, et al
     Pharmacodynamics of PEG-IFN alpha differentiate HIV/HCV coinfected sustained virological responders from nonresponders.
     Hepatology. 2006;43:943-53.
     PubMed     Related articles    Abstract available
     
     
     April 2006
210. GIANNINI C , Giannelli F, Linda Zignego A
     Association between mixed cryoglobulinemia, translocation (14;18), and persistence of occult HCV lymphoid infection after treatment.
     Hepatology. 2006;43:1166-1167.
     PubMed     Related articles   
     
     
     
211. JENSEN DM , Morgan TR, Marcellin P, Pockros PJ, et al
     Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40 kd)/ribavirin therapy.
     Hepatology. 2006;43:954-960.
     PubMed     Related articles    Abstract available
     
     
     
212. VON HAHN T , Lindenbach BD, Boullier A, Quehenberger O, et al
     Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells.
     Hepatology. 2006;43:932-942.
     PubMed     Related articles    Abstract available
     
     
     
213. STRICKLAND GT
     Liver disease in Egypt: Hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors.
     Hepatology. 2006;43:915-922.
     PubMed     Related articles    Abstract available
     
     
     
214. DAVIS GL
     Tailoring antiviral therapy in hepatitis C.
     Hepatology. 2006;43:909-911.
     PubMed     Related articles   
     
     
     
215. DREUX M , Cosset FL
     HCV and lipoproteins: Is oxLDL an Achilles' heel of the Trojan horse?
     Hepatology. 2006;43:903-905.
     PubMed     Related articles   
     
     
     
216. HARRISON SA
     Correlation between insulin resistance and hepatitis C viral load.
     Hepatology. 2006;43:1168.
     PubMed     Related articles   
     
     
     
217. KAMAL SM , Moustafa KN, Chen J, Fehr J, et al
     Duration of peginterferon therapy in acute hepatitis C: A randomized trial.
     Hepatology. 2006;43:923-931.
     PubMed     Related articles    Abstract available
     
     
     
218. KUIKEN C , Mizokami M, Deleage G, Yusim K, et al
     Hepatitis C databases, principles and utility to researchers.
     Hepatology. 2006;43:1157-1165.
     PubMed     Related articles    Abstract available
     
     
     
219. CALLENDER GG , Rosen HR, Roszkowski JJ, Lyons GE, et al
     Identification of a hepatitis C virus-reactive T cell receptor that does not require CD8 for target cell recognition.
     Hepatology. 2006;43:973-981.
     PubMed     Related articles    Abstract available
     
     
     
220. LANFORD RE , Guerra B, Lee H, Chavez D, et al
     Genomic response to interferon-alpha in chimpanzees: Implications of rapid downregulation for hepatitis C kinetics.
     Hepatology. 2006;43:961-972.
     PubMed     Related articles    Abstract available
     
     
     
221. BRANDA M , Wands JR
     Signal transduction cascades and hepatitis B and C related hepatocellular carcinoma.
     Hepatology. 2006;43:891-902.
     PubMed     Related articles   
     
     
     
222. LIM R , Knight B, Patel K, McHutchison JG, et al
     Antiproliferative effects of interferon alpha